The Global White Paper is the first publication of the International Forum for Antibiotic Resistance (IFAR), a new multi-disciplinary group of world-renowned experts from six continents including infectious disease specialists, microbiologists, epidemiologists and the International Alliance of Patients Organisations (IAPO).
The paper was presented during a symposium officially supported by the Infectious Disease Society of America (IDSA), the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), and the International Society for Infectious Diseases (ISID) with the participation of the Centers for Disease Control and Prevention (CDC).
"Despite numerous international and national recommendations for resistance control, few large-scale interventions have been implemented and audited and little has been accomplished in the fight against resistant bacteria," explained Prof. Roger G. Finch, President of ESCMID and Professor of Infectious Diseases, The City Hospital and University of Nottingham, Nottingham, UK, a co-editor of the paper. "The 'Global White Paper on Bacterial Resistance in Respiratory Tract Infections' is long overdue and has come at a crucial time to help focus on what needs to be achieved to tackle the ever-increasing problem of antimicrobial resistance".
Community-acquired respiratory tract infections (RTIs) are a major public health concern in terms of morbidity
'"/>
Contact: Roseann Ward
roseann.ward@ketchum.com
44-207-611-3661
Ketchum
17-Dec-2001